Matthew During - Publications

Affiliations: 
Univ Auckland, Auckland, Auckland, New Zealand 

73/271 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 During MJ, Liu X, Huang W, Magee D, Slater A, McMurphy T, Wang C, Cao L. Adipose VEGF Links the White-to-Brown Fat Switch With Environmental, Genetic, and Pharmacological Stimuli in Male Mice. Endocrinology. 156: 2059-73. PMID 25763639 DOI: 10.1210/en.2014-1905  0.708
2015 Charbonnier-Beaupel F, Malerbi M, Alcacer C, Tahiri K, Carpentier W, Wang C, During M, Xu D, Worley PF, Girault JA, Hervé D, Corvol JC. Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 96-111. PMID 25568106 DOI: 10.1523/JNEUROSCI.5231-13.2015  0.712
2014 Liu X, Magee D, Wang C, McMurphy T, Slater A, During M, Cao L. Adipose tissue insulin receptor knockdown via a new primate-derived hybrid recombinant AAV serotype. Molecular Therapy. Methods & Clinical Development. 1. PMID 25383359 DOI: 10.1038/mtm.2013.8  0.719
2014 Lin EJ, Symes CW, Townsend-Nicholson A, Klugmann M, Klugmann CB, Lehnert K, Fong D, Young D, During MJ. An Immunological Approach to Increase the Brain's Resilience to Insults. Isrn Neuroscience. 2014: 103213. PMID 24967312 DOI: 10.1155/2014/103213  0.563
2014 Baldock PA, Lin S, Zhang L, Karl T, Shi Y, Driessler F, Zengin A, Hörmer B, Lee NJ, Wong IP, Lin EJ, Enriquez RF, Stehrer B, During MJ, Yulyaningsih E, et al. Neuropeptide y attenuates stress-induced bone loss through suppression of noradrenaline circuits. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 29: 2238-49. PMID 24535841 DOI: 10.1002/jbmr.2205  0.309
2013 Blouin AM, Stern AL, Han S, Theberge FR, Wang C, During MJ, Baraban JM, Reti IM. Neuronal activity-regulated pentraxin expressed in medial prefrontal cortex neurons is not necessary for extinction of heroin self-administration. Behavioural Pharmacology. 24: 332-6. PMID 23751516 DOI: 10.1097/Fbp.0B013E328363367B  0.698
2013 Carruthers KH, During MJ, Muravlev A, Wang C, Kocak E. Fat grafting as a vehicle for the delivery of recombinant adenoassociated viral vectors to achieve gene modification of muscle flaps. Annals of Plastic Surgery. 70: 726-31. PMID 23403543 DOI: 10.1097/SAP.0b013e3182414add  0.679
2013 Blouin AM, Han S, Pearce AM, Cheng K, Lee JJ, Johnson AW, Wang C, During MJ, Holland PC, Shaham Y, Baraban JM, Reti IM. Role of medial prefrontal cortex Narp in the extinction of morphine conditioned place preference. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 75-9. PMID 23322555 DOI: 10.1101/Lm.028621.112  0.684
2012 Akil O, Seal RP, Burke K, Wang C, Alemi A, During M, Edwards RH, Lustig LR. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron. 75: 283-93. PMID 22841313 DOI: 10.1016/j.neuron.2012.05.019  0.714
2012 Naughton BJ, Thirtamara-Rajamani K, Wang C, During MJ, Gu HH. Specific knockdown of the D2 long dopamine receptor variant. Neuroreport. 23: 1-5. PMID 22082989 DOI: 10.1097/WNR.0b013e32834d2216  0.705
2011 Gray JA, Shi Y, Usui H, During MJ, Sakimura K, Nicoll RA. Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron. 71: 1085-101. PMID 21943605 DOI: 10.1016/J.Neuron.2011.08.007  0.414
2011 Cao L, Choi EY, Liu X, Martin A, Wang C, Xu X, During MJ. White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metabolism. 14: 324-38. PMID 21907139 DOI: 10.1016/j.cmet.2011.06.020  0.715
2011 Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, During M, Kholodilov N, Burke RE. Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration. Annals of Neurology. 70: 110-20. PMID 21437936 DOI: 10.1002/ana.22383  0.743
2011 Cheng HC, Kim SR, Oo TF, Kareva T, Yarygina O, Rzhetskaya M, Wang C, During M, Talloczy Z, Tanaka K, Komatsu M, Kobayashi K, Okano H, Kholodilov N, Burke RE. Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 2125-35. PMID 21307249 DOI: 10.1523/Jneurosci.5519-10.2011  0.733
2011 Lu W, Gray JA, Granger AJ, During MJ, Nicoll RA. Potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunit. Journal of Neurophysiology. 105: 923-8. PMID 20980546 DOI: 10.1152/Jn.00725.2010  0.415
2010 Cao L, Liu X, Lin EJ, Wang C, Choi EY, Riban V, Lin B, During MJ. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell. 142: 52-64. PMID 20603014 DOI: 10.1016/j.cell.2010.05.029  0.708
2009 Ries V, Cheng HC, Baohan A, Kareva T, Oo TF, Rzhetskaya M, Bland RJ, During MJ, Kholodilov N, Burke RE. Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B. Journal of Neurochemistry. 110: 23-33. PMID 19490361 DOI: 10.1111/j.1471-4159.2009.06101.x  0.456
2009 Lu W, Shi Y, Jackson AC, Bjorgan K, During MJ, Sprengel R, Seeburg PH, Nicoll RA. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron. 62: 254-68. PMID 19409270 DOI: 10.1016/J.Neuron.2009.02.027  0.412
2009 Noé F, Frasca A, Balducci C, Carli M, Sperk G, Ferraguti F, Pitkänen A, Bland R, Fitzsimons H, During M, Vezzani A. Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 300-6. PMID 19332323 DOI: 10.1016/J.Nurt.2009.01.012  0.311
2009 Cao L, Lin EJ, Cahill MC, Wang C, Liu X, During MJ. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nature Medicine. 15: 447-54. PMID 19270710 DOI: 10.1038/nm.1933  0.709
2008 Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 947-56. PMID 18388917 DOI: 10.1038/Mt.2008.50  0.588
2008 Adesnik H, Li G, During MJ, Pleasure SJ, Nicoll RA. NMDA receptors inhibit synapse unsilencing during brain development. Proceedings of the National Academy of Sciences of the United States of America. 105: 5597-602. PMID 18375768 DOI: 10.1073/pnas.0800946105  0.43
2008 Chen X, Rzhetskaya M, Kareva T, Bland R, During MJ, Tank AW, Kholodilov N, Burke RE. Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 672-80. PMID 18199767 DOI: 10.1523/Jneurosci.2132-07.2008  0.446
2007 Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, Hunter M, Fairlie WD, Lee NJ, Enriquez RF, Baldock PA, ... ... During MJ, et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nature Medicine. 13: 1333-40. PMID 17982462 DOI: 10.1038/Nm1677  0.684
2006 Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, During MJ, Kholodilov N, Burke RE. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 18757-62. PMID 17116866 DOI: 10.1073/pnas.0606401103  0.481
2006 Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron. 51: 455-66. PMID 16908411 DOI: 10.1016/J.Neuron.2006.07.006  0.676
2006 Allison SJ, Baldock P, Sainsbury A, Enriquez R, Lee NJ, Lin EJ, Klugmann M, Klugman M, During M, Eisman JA, Li M, Pan LC, Herzog H, Gardiner EM. Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice. The Journal of Biological Chemistry. 281: 23436-44. PMID 16785231 DOI: 10.1074/jbc.M604839200  0.578
2006 Tappe A, Klugmann M, Luo C, Hirlinger D, Agarwal N, Benrath J, Ehrengruber MU, During MJ, Kuner R. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nature Medicine. 12: 677-81. PMID 16715092 DOI: 10.1038/Nm1406  0.542
2006 Robinson S, Sotak BN, During MJ, Palmiter RD. Local dopamine production in the dorsal striatum restores goal-directed behavior in dopamine-deficient mice. Behavioral Neuroscience. 120: 196-200. PMID 16492130 DOI: 10.1037/0735-7044.120.1.000  0.458
2006 Olson VG, Heusner CL, Bland RJ, During MJ, Weinshenker D, Palmiter RD. Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward. Science (New York, N.Y.). 311: 1017-20. PMID 16484499 DOI: 10.1126/Science.1119311  0.449
2006 During MJ, Cao L. VEGF, a mediator of the effect of experience on hippocampal neurogenesis. Current Alzheimer Research. 3: 29-33. PMID 16472200 DOI: 10.2174/156720506775697133  0.327
2006 Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D, During MJ. A novel role of circadian transcription factor DBP in hippocampal plasticity. Molecular and Cellular Neurosciences. 31: 303-14. PMID 16257226 DOI: 10.1016/J.Mcn.2005.09.019  0.577
2006 Szumlinski KK, Abernathy KE, Oleson EB, Klugmann M, Lominac KD, He DY, Ron D, During M, Kalivas PW. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 768-77. PMID 16160706 DOI: 10.1038/Sj.Npp.1300890  0.593
2006 Tappe A, Klugmann M, Luo C, Hirlinger D, Agarwal N, Benrath J, Ehrengruber M, During M. 353 SYNAPTIC SCAFFOLDING PROTEIN HOMER1A PROTECTS AGAINST INFLAMMATORY PAIN European Journal of Pain. 10: S94a-S94. DOI: 10.1016/S1090-3801(06)60356-X  0.496
2005 Lominac KD, Oleson EB, Pava M, Klugmann M, Schwarz MK, Seeburg PH, During MJ, Worley PF, Kalivas PW, Szumlinski KK. Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11586-94. PMID 16354916 DOI: 10.1523/Jneurosci.3764-05.2005  0.583
2005 Szumlinski KK, Lominac KD, Oleson EB, Walker JK, Mason A, Dehoff MH, Klugmann M, Klugman M, Cagle S, Welt K, During M, Worley PF, Middaugh LD, Kalivas PW. Homer2 is necessary for EtOH-induced neuroplasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7054-61. PMID 16049182 DOI: 10.1523/Jneurosci.1529-05.2005  0.643
2005 Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D, During MJ. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 745-53. PMID 15851013 DOI: 10.1016/J.Ymthe.2005.01.006  0.577
2005 Klugmann M, Symes CW, Leichtlein CB, Klaussner BK, Dunning J, Fong D, Young D, During MJ. AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Molecular and Cellular Neurosciences. 28: 347-60. PMID 15691715 DOI: 10.1016/J.Mcn.2004.10.002  0.533
2004 Cannon CM, Abdallah L, Tecott LH, During MJ, Palmiter RD. Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice. Neuron. 44: 509-20. PMID 15504330 DOI: 10.1016/j.neuron.2004.10.009  0.484
2004 Hnasko TS, Szczypka MS, Alaynick WA, During MJ, Palmiter RD. A role for dopamine in feeding responses produced by orexigenic agents. Brain Research. 1023: 309-18. PMID 15374756 DOI: 10.1016/J.Brainres.2004.07.051  0.46
2004 Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M, Rohrer J, Griffin W, Toda S, Champtiaux NP, Berry T, Tu JC, Shealy SE, During MJ, Middaugh LD, et al. Homer proteins regulate sensitivity to cocaine. Neuron. 43: 401-13. PMID 15294147 DOI: 10.1016/J.Neuron.2004.07.019  0.556
2004 Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, During MJ. VEGF links hippocampal activity with neurogenesis, learning and memory. Nature Genetics. 36: 827-35. PMID 15258583 DOI: 10.1038/ng1395  0.307
2003 Klugmann M, Symes CW, Klaussner BK, Leichtlein CB, Serikawa T, Young D, During MJ. Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport. 14: 1837-40. PMID 14534431 DOI: 10.1097/00001756-200310060-00016  0.552
2003 During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Medicine. 9: 1173-9. PMID 12925848 DOI: 10.1038/Nm919  0.606
2003 Heusner CL, Hnasko TS, Szczypka MS, Liu Y, During MJ, Palmiter RD. Viral restoration of dopamine to the nucleus accumbens is sufficient to induce a locomotor response to amphetamine. Brain Research. 980: 266-74. PMID 12867267 DOI: 10.1016/S0006-8993(03)02986-X  0.472
2003 During MJ, Young D, Baer K, Lawlor P, Klugmann M. Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods in Molecular Medicine. 76: 221-36. PMID 12526166 DOI: 10.1385/1-59259-304-6:221  0.516
2002 Cao L, During M, Xiao W. Replication competent helper functions for recombinant AAV vector generation. Gene Therapy. 9: 1199-206. PMID 12215886 DOI: 10.1038/Sj.Gt.3301710  0.4
2002 Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, Kerr D, Leone P, Krystal JH, Spencer DD, During MJ, Sherwin RS. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 22: 271-9. PMID 11891432 DOI: 10.1097/00004647-200203000-00004  0.397
2001 Fitzsimons HL, Mckenzie JM, During MJ. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Therapy. 8: 1675-81. PMID 11892834 DOI: 10.1038/sj.gt.3301582  0.328
2000 Cao L, Liu Y, During MJ, Xiao W. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids. Journal of Virology. 74: 11456-63. PMID 11090141 DOI: 10.1128/Jvi.74.24.11456-11463.2000  0.325
1998 During MJ, Samulski RJ, Elsworth JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH, Sladek JR, O'Malley KL, Redmond DE. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Therapy. 5: 820-7. PMID 9747462 DOI: 10.1038/Sj.Gt.3300650  0.67
1995 During MJ, Ryder KM, Spencer DD. Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature. 376: 174-7. PMID 7603569 DOI: 10.1038/376174a0  0.398
1994 During MJ, Fried I, Leone P, Katz A, Spencer DD. Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures. Journal of Neurochemistry. 62: 2356-61. PMID 8189240 DOI: 10.1046/J.1471-4159.1994.62062356.X  0.396
1994 Scheyer RD, During MJ, Spencer DD, Cramer JA, Mattson RH. Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis. Neurology. 44: 1469-72. PMID 8058151 DOI: 10.1212/Wnl.44.8.1469  0.383
1994 Scheyer RD, During MJ, Hochholzer JM, Spencer DD, Cramer JA, Mattson RH. Phenytoin concentrations in the human brain: an in vivo microdialysis study. Epilepsy Research. 18: 227-32. PMID 7805644 DOI: 10.1016/0920-1211(94)90043-4  0.39
1993 Sybirska E, Seibyl JP, Bremner JD, Baldwin RM, al-Tikriti MS, Bradberry C, Malison RT, Zea-Ponce Y, Zoghbi S, During M. [123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain. Neuropharmacology. 32: 671-80. PMID 8395663 DOI: 10.1016/0028-3908(93)90080-M  0.6
1993 During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet. 341: 1607-10. PMID 8099987 DOI: 10.1016/0140-6736(93)90754-5  0.391
1992 During MJ, Freese A, Deutch AY, Kibat PG, Sabel BA, Langer R, Roth RH. Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. Experimental Neurology. 115: 193-9. PMID 1735466 DOI: 10.1016/0014-4886(92)90053-S  0.644
1992 During MJ, Spencer DD. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Annals of Neurology. 32: 618-24. PMID 1449242 DOI: 10.1002/ana.410320504  0.387
1992 During MJ, Bean AJ, Roth RH. Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neuroscience Letters. 140: 129-33. PMID 1407692 DOI: 10.1016/0304-3940(92)90698-7  0.464
1991 During MJ, Heyes MP, Freese A, Swartz KJ, Matson WR, Markey SP, Martin JB, Roth RH. Indolic and kynurenine pathway metabolites of tryptophan in rat brain: effect of precursor availability on in vivo release. Advances in Experimental Medicine and Biology. 294: 535-9. PMID 1837690 DOI: 10.1007/978-1-4684-5952-4_62  0.413
1990 Deutch AY, During MJ. A cautionary note on the potential benefits of striatal dopamine implants. Annals of Neurology. 28: 111. PMID 2375628 DOI: 10.1002/Ana.410280127  0.517
1990 Bean AJ, During MJ, Roth RH. Effects of dopamine autoreceptor stimulation on the release of colocalized transmitters: in vivo release of dopamine and neurotensin from rat prefrontal cortex. Neuroscience Letters. 108: 143-8. PMID 2304623 DOI: 10.1016/0304-3940(90)90721-K  0.448
1989 Conlay LA, Wurtman RJ, Lopez G-Coviella I, Blusztajn JK, Vacanti CA, Logue M, During M, Caballero B, Maher TJ, Evoniuk G. Effects of running the Boston marathon on plasma concentrations of large neutral amino acids. Journal of Neural Transmission. 76: 65-71. PMID 2708978 DOI: 10.1007/BF01244992  0.727
1989 During MJ, Freese A, Sabel BA, Saltzman WM, Deutch A, Roth RH, Langer R. Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Annals of Neurology. 25: 351-6. PMID 2634975 DOI: 10.1002/Ana.410250406  0.626
1989 Bean AJ, During MJ, Deutch AY, Roth RH. Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 4430-8. PMID 2593006 DOI: 10.1523/Jneurosci.09-12-04430.1989  0.676
1989 Bean AJ, During MJ, Roth RH. Stimulation-induced release of coexistent transmitters in the prefrontal cortex: an in vivo microdialysis study of dopamine and neurotensin release. Journal of Neurochemistry. 53: 655-7. PMID 2568407 DOI: 10.1111/J.1471-4159.1989.Tb07384.X  0.447
1989 During MJ, Freese A, Heyes MP, Swartz KJ, Markey SP, Roth RH, Martin JB. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. Febs Letters. 247: 438-44. PMID 2523822 DOI: 10.1016/0014-5793(89)81387-0  0.41
1989 During MJ, Heyes MP, Freese A, Markey SP, Martin JB, Roth RH. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading. Brain Research. 476: 384-7. PMID 2522807 DOI: 10.1016/0006-8993(89)91265-1  0.405
1989 During MJ, Acworth IN, Wurtman RJ. Dopamine release in rat striatum: physiological coupling to tyrosine supply. Journal of Neurochemistry. 52: 1449-54. PMID 2496199 DOI: 10.1111/j.1471-4159.1989.tb09192.x  0.7
1988 During MJ, Acworth IN, Wurtman RJ. Effects of systemic L-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens. Brain Research. 452: 378-80. PMID 3401745 DOI: 10.1016/0006-8993(88)90043-1  0.689
1988 Acworth IN, During MJ, Wurtman RJ. Tyrosine: effects on catecholamine release. Brain Research Bulletin. 21: 473-7. PMID 3214752 DOI: 10.1016/0361-9230(88)90161-X  0.696
1988 During MJ, Acworth IN, Wurtman RJ. Phenylalanine administration influences dopamine release in the rat's corpus striatum. Neuroscience Letters. 93: 91-5. PMID 3211373 DOI: 10.1016/0304-3940(88)90018-3  0.686
Low-probability matches (unlikely to be authored by this person)
2005 Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 20: 1851-7. PMID 16160743 DOI: 10.1359/JBMR.050523  0.299
2009 Allison SJ, Baldock PA, Enriquez RF, Lin E, During M, Gardiner EM, Eisman JA, Sainsbury A, Herzog H. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 294-304. PMID 18847327 DOI: 10.1359/jbmr.081013  0.295
2003 Ma H, Xu R, Cheng H, Kuo HS, During M, Fang RH. Gene transfer into human keloid tissue with adeno-associated virus vector. The Journal of Trauma. 54: 569-73. PMID 12634540 DOI: 10.1097/01.TA.0000042016.45195.4C  0.292
2012 Cao L, During MJ. What is the brain-cancer connection? Annual Review of Neuroscience. 35: 331-45. PMID 22462541 DOI: 10.1146/annurev-neuro-062111-150546  0.29
2007 Noe' F, Nissinen J, Pitkänen A, Gobbi M, Sperk G, During M, Vezzani A. Gene therapy in epilepsy: the focus on NPY. Peptides. 28: 377-83. PMID 17196301 DOI: 10.1016/j.peptides.2006.07.025  0.29
1997 Jacob RJ, Dziura J, Medwick MB, Leone P, Caprio S, During M, Shulman GI, Sherwin RS. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes. 46: 150-2. PMID 8971096 DOI: 10.2337/Diab.46.1.150  0.29
2000 Dragunow M, Xu R, Walton M, Woodgate A, Lawlor P, MacGibbon GA, Young D, Gibbons H, Lipski J, Muravlev A, Pearson A, During M. c-Jun promotes neurite outgrowth and survival in PC12 cells. Brain Research. Molecular Brain Research. 83: 20-33. PMID 11072092 DOI: 10.1016/S0169-328X(00)00191-1  0.278
2003 Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiology of Disease. 14: 535-41. PMID 14678769 DOI: 10.1016/J.Nbd.2003.08.025  0.278
2009 Baldock PA, Lee NJ, Driessler F, Lin S, Allison S, Stehrer B, Lin EJ, Zhang L, Enriquez RF, Wong IP, McDonald MM, During M, Pierroz DD, Slack K, Shi YC, et al. Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. Plos One. 4: e8415. PMID 20027231 DOI: 10.1371/journal.pone.0008415  0.269
1988 Freese A, Schwartz KJ, During M. Potential neurotoxicity of tryptophan. Annals of Internal Medicine. 108: 312-3. PMID 3341669 DOI: 10.7326/0003-4819-108-2-312_2  0.261
2002 Peterson TC, Peterson MR, Robertson HA, During M, Dragunow M. Selective down-regulation of c-jun gene expression by pentoxifylline and c-jun antisense interrupts platelet-derived growth factor signaling: pentoxifylline inhibits phosphorylation of c-Jun on serine 73. Molecular Pharmacology. 61: 1476-88. PMID 12021409 DOI: 10.1124/Mol.61.6.1476  0.258
2011 Kocak E, Carruthers K, Miller M, During M. 74: GENE MODIFICATION OF MUSCLE FLAPS USING NOVEL RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS Plastic and Reconstructive Surgery. 127: 45. DOI: 10.1097/01.prs.0000396761.84722.f0  0.252
2004 Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 682-8. PMID 15120329 DOI: 10.1016/J.Ymthe.2004.02.016  0.252
2003 Janson CG, During M, Shifman Y, Leone P. Transcriptional activation of human CREB gene promoter using bis-PNA (peptide nucleic acid) Letters in Peptide Science. 10: 373-376. DOI: 10.1007/BF02484572  0.251
2002 Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML, During MJ. Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science (New York, N.Y.). 298: 425-9. PMID 12376704 DOI: 10.1126/Science.1074549  0.251
1998 Song S, Wang Y, Bak SY, During MJ, Bryan J, Ashe O, Ullrey DB, Trask LE, Grant FD, O'Malley KL, Riedel H, Goldstein DS, Neve KA, LaHoste GJ, Marshall JF, et al. Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 4119-32. PMID 9592092 DOI: 10.1523/Jneurosci.18-11-04119.1998  0.245
1994 During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science (New York, N.Y.). 266: 1399-403. PMID 7669103 DOI: 10.1126/Science.266.5189.1399  0.242
2010 Johnson AW, Han S, Blouin AM, Saini J, Worley PF, During MJ, Holland PC, Baraban JM, Reti IM. Localized disruption of Narp in medial prefrontal cortex blocks reinforcer devaluation performance. Learning & Memory (Cold Spring Harbor, N.Y.). 17: 620-6. PMID 21127001 DOI: 10.1101/Lm.1937210  0.24
1994 Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genetics. 8: 148-54. PMID 7842013 DOI: 10.1038/Ng1094-148  0.232
1996 During M. Gene therapy in New Zealand. Science (New York, N.Y.). 272: 467. PMID 8614786 DOI: 10.1126/Science.272.5261.467A  0.228
1996 Freese A, During MJ, Davidson BL, Gennarelli TA, Kaplitt MG, Flamm ES, Snyder PJ. Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release. The Journal of Clinical Endocrinology and Metabolism. 81: 2401-4. PMID 8964885 DOI: 10.1210/Jcem.81.6.8964885  0.228
2009 Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ. Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1692-702. PMID 19638961 DOI: 10.1038/mt.2009.170  0.225
1996 During M. Gene therapy chronology. Science (New York, N.Y.). 273: 416b-7b. PMID 17776181 DOI: 10.1126/science.273.5274.416b  0.223
2001 During MJ, Kaplitt MG, Stern MB, Eidelberg D. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Human Gene Therapy. 12: 1589-91. PMID 11529246  0.221
2008 Fitzgibbon BM, Fairhall SL, Kirk IJ, Kalev-Zylinska M, Pui K, Dalbeth N, Keelan S, Robinson E, During M, McQueen FM. Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls. Rheumatology (Oxford, England). 47: 50-3. PMID 18037687 DOI: 10.1093/Rheumatology/Kem287  0.221
1991 Neve RL, Ivins KJ, Benowitz LI, During MJ, Geller AI. Molecular analysis of the function of the neuronal growth-associated protein GAP-43 by genetic intervention. Molecular Neurobiology. 5: 131-41. PMID 1668383 DOI: 10.1007/Bf02935542  0.219
2009 Lin S, Shi YC, Yulyaningsih E, Aljanova A, Zhang L, Macia L, Nguyen AD, Lin EJ, During MJ, Herzog H, Sainsbury A. Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice. Plos One. 4: e8488. PMID 20041129 DOI: 10.1371/journal.pone.0008488  0.211
2014 Young D, Fong DM, Lawlor PA, Wu A, Mouravlev A, McRae M, Glass M, Dragunow M, During MJ. Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy. Gene Therapy. 21: 1029-40. PMID 25231174 DOI: 10.1038/Gt.2014.82  0.21
2008 Sørensen AT, Kanter-Schlifke I, Lin EJ, During MJ, Kokaia M. Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Molecular and Cellular Neurosciences. 39: 229-37. PMID 18652899 DOI: 10.1016/j.mcn.2008.06.014  0.21
2003 McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Experimental Neurology. 181: 213-23. PMID 12781994 DOI: 10.1016/S0014-4886(03)00044-X  0.207
1997 Freese A, Kaplitt MG, O'Connor WM, Abbey M, Langer D, Leone P, O'Connor MJ, During MJ. Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy. Epilepsia. 38: 759-66. PMID 9579902 DOI: 10.1111/J.1528-1157.1997.Tb01462.X  0.203
2010 Fitzsimons HL, Riban V, Bland RJ, Wendelken JL, Sapan CV, During MJ. Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat. The Journal of Gene Medicine. 12: 385-98. PMID 20352617 DOI: 10.1002/jgm.1449  0.201
2001 Mastakov MY, Baer K, Xu R, Fitzsimons H, During MJ. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 225-32. PMID 11237679 DOI: 10.1006/mthe.2001.0246  0.2
2010 Noe F, Vaghi V, Balducci C, Fitzsimons H, Bland R, Zardoni D, Sperk G, Carli M, During MJ, Vezzani A. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus. Gene Therapy. 17: 643-52. PMID 20220782 DOI: 10.1038/Gt.2010.23  0.2
1997 O'Connor WM, Davidson BL, Kaplitt MG, Abbey MV, During MJ, Leone P, Langer D, O'Connor MJ, Freese A. Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsy. Experimental Neurology. 148: 167-78. PMID 9398459 DOI: 10.1006/Exnr.1997.6658  0.2
2007 Mouravlev A, Young D, During MJ. Phosphorylation-dependent degradation of transgenic CREB protein initiated by heterodimerization. Brain Research. 1130: 31-7. PMID 17169345 DOI: 10.1016/j.brainres.2006.10.076  0.198
2001 Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A, Fitzsimons H, Choi KL, Ma H, Dragunow M, Leone P, Chen Q, Dicker B, During MJ. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Therapy. 8: 1323-32. PMID 11571569 DOI: 10.1038/Sj.Gt.3301529  0.197
2000 Leone P, Janson CG, Bilaniuk L, Wang Z, Sorgi F, Huang L, Matalon R, Kaul R, Zeng Z, Freese A, McPhee SW, Mee E, During MJ, Bilianuk L. Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Annals of Neurology. 48: 27-38. PMID 10894213  0.197
1991 Geller AI, During MJ, Neve RL. Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors. Trends in Neurosciences. 14: 428-32. PMID 1722360  0.197
2008 Reti IM, Miskimon M, Dickson M, Petralia RS, Takamiya K, Bland R, Saini J, During MJ, Huganir RL, Baraban JM. Activity-dependent secretion of neuronal activity regulated pentraxin from vasopressin neurons into the systemic circulation. Neuroscience. 151: 352-60. PMID 18082971 DOI: 10.1016/J.Neuroscience.2007.10.040  0.196
1990 Swartz KJ, During MJ, Freese A, Beal MF. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2965-73. PMID 2168940  0.195
1993 Geller AI, During MJ, Haycock JW, Freese A, Neve R. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proceedings of the National Academy of Sciences of the United States of America. 90: 7603-7. PMID 8102799  0.192
2014 O'Neill B, Tilley MR, Han DD, Thirtamara-Rajamani K, Hill ER, Bishop GA, Zhou FM, During MJ, Gu HH. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum. Neuropharmacology. 79: 626-33. PMID 24412674 DOI: 10.1016/J.Neuropharm.2013.12.023  0.192
2002 Mastakov MY, Baer K, Kotin RM, During MJ. Recombinant adeno-associated virus serotypes 2- and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 371-80. PMID 11945063 DOI: 10.1006/Mthe.2002.0564  0.191
2004 Lawlor PA, During MJ. Gene therapy for Parkinson's disease. Expert Reviews in Molecular Medicine. 6: 1-18. PMID 15000692 DOI: 10.1017/S146239940400746X  0.188
2004 Francis JS, Dragunow M, During MJ. Over expression of ATF-3 protects rat hippocampal neurons from in vivo injection of kainic acid. Brain Research. Molecular Brain Research. 124: 199-203. PMID 15135228 DOI: 10.1016/J.Molbrainres.2003.10.027  0.188
2010 Lin EJ, Lin S, Aljanova A, During MJ, Herzog H. Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 164-75. PMID 19781916 DOI: 10.1016/j.euroneuro.2009.08.004  0.186
2000 Leone P, McPhee SW, Janson CG, Davidson BL, Freese A, During MJ. Multi-site partitioned delivery of human tyrosine hydroxylase gene with phenotypic recovery in Parkinsonian rats. Neuroreport. 11: 1145-51. PMID 10817582 DOI: 10.1097/00001756-200004270-00002  0.185
2004 Noordmans AJ, Song DK, Noordmans CJ, Garrity-Moses M, During MJ, Fitzsimons HL, Imperiale MJ, Boulis NM. Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior. Gene Therapy. 11: 797-804. PMID 14961066 DOI: 10.1038/Sj.Gt.3302223  0.185
2008 Sørensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, During MJ, Vezzani A, Kokaia M. NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus. 18: 564-74. PMID 18306304 DOI: 10.1002/Hipo.20415  0.183
1995 Geller AI, During MJ, Oh YJ, Freese A, O'Malley K. An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells. Journal of Neurochemistry. 64: 487-96. PMID 7830040 DOI: 10.1046/J.1471-4159.1995.64020487.X  0.183
2007 Brouillette J, Young D, During MJ, Quirion R. Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. Journal of Neurochemistry. 102: 1978-89. PMID 17540011 DOI: 10.1111/j.1471-4159.2007.04666.x  0.182
2003 Waldvogel HJ, Baer K, Snell RG, During MJ, Faull RL, Rees MI. Distribution of gephyrin in the human brain: an immunohistochemical analysis. Neuroscience. 116: 145-56. PMID 12535948 DOI: 10.1016/S0306-4522(02)00550-X  0.182
2020 Nishi T, Kondo S, Miyamoto M, Watanabe S, Hasegawa S, Kondo S, Yano J, Watanabe E, Ishi T, Yoshikawa M, Ando HK, Farnaby W, Fujimoto S, Sunahara E, Ohori M, ... During MJ, et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Scientific Reports. 10: 17081. PMID 33051477 DOI: 10.1038/s41598-020-74036-6  0.182
2002 Mastakov MY, Baer K, Symes CW, Leichtlein CB, Kotin RM, During MJ. Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. Journal of Virology. 76: 8446-54. PMID 12134047 DOI: 10.1128/Jvi.76.16.8446-8454.2002  0.181
2009 Riban V, Fitzsimons HL, During MJ. Gene therapy in epilepsy. Epilepsia. 50: 24-32. PMID 18717707 DOI: 10.1111/j.1528-1167.2008.01743.x  0.18
1989 Freese A, Sabel BA, Saltzman WM, During MJ, Langer R. Controlled release of dopamine from a polymeric brain implant: in vitro characterization. Experimental Neurology. 103: 234-8. PMID 2920789 DOI: 10.1016/0014-4886(89)90047-2  0.177
1993 Perry VL, Young RS, Aquila WJ, During MJ. Effect of experimental Escherichia coli meningitis on concentrations of excitatory and inhibitory amino acids in the rabbit brain: in vivo microdialysis study. Pediatric Research. 34: 187-91. PMID 7901833 DOI: 10.1203/00006450-199308000-00017  0.177
2004 Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3051-9. PMID 15044544 DOI: 10.1523/JNEUROSCI.4056-03.2004  0.177
2007 Lin S, Lin EJ, Boey D, Lee NJ, Slack K, During MJ, Sainsbury A, Herzog H. Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways. Endocrinology. 148: 2056-65. PMID 17272395 DOI: 10.1210/en.2006-1408  0.175
2013 Charbel Issa P, De Silva SR, Lipinski DM, Singh MS, Mouravlev A, You Q, Barnard AR, Hankins MW, During MJ, Maclaren RE. Assessment of tropism and effectiveness of new primate-derived hybrid recombinant AAV serotypes in the mouse and primate retina. Plos One. 8: e60361. PMID 23593201 DOI: 10.1371/Journal.Pone.0060361  0.175
2013 Kocak E, Carruthers K, Choi E, During M. Abstract 199 Plastic and Reconstructive Surgery. 131: 146. DOI: 10.1097/01.prs.0000430141.11999.a7  0.174
1996 Freese A, Stern M, Kaplitt MG, O'Connor WM, Abbey MV, O'Connor MJ, During MJ. Prospects for gene therapy in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 469-88. PMID 8866488 DOI: 10.1002/Mds.870110502  0.173
2001 Janson CG, During MJ. Viral vectors as part of an integrated functional genomics program. Genomics. 78: 3-6. PMID 11707065 DOI: 10.1006/geno.2001.6653  0.172
2006 Lin EJ, Young D, Baer K, Herzog H, During MJ. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice. Epilepsia. 47: 773-80. PMID 16650144 DOI: 10.1111/j.1528-1167.2006.00500.x  0.169
2007 Emborg ME, Carbon M, Holden JE, During MJ, Ma Y, Tang C, Moirano J, Fitzsimons H, Roitberg BZ, Tuccar E, Roberts A, Kaplitt MG, Eidelberg D. Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 501-9. PMID 16835631 DOI: 10.1038/Sj.Jcbfm.9600364  0.166
1995 Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes. 44: 180-4. PMID 7859938 DOI: 10.2337/Diab.44.2.180  0.165
1998 Kaplitt MG, Darakchiev B, During MJ. Prospects for gene therapy in pediatric neurosurgery. Pediatric Neurosurgery. 28: 3-14. PMID 9693323 DOI: 10.1159/000028611  0.165
2007 Tiesjema B, la Fleur SE, Luijendijk MC, Brans MA, Lin EJ, During MJ, Adan RA. Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity. Obesity (Silver Spring, Md.). 15: 2424-35. PMID 17925468 DOI: 10.1038/oby.2007.288  0.165
2017 Levin JM, Holtzman SH, Maraganore J, Hastings PJ, Cohen R, Dahiyat B, Adams J, Adams C, Ahrens B, Albers J, Aspinall MG, Audia JE, Babler M, Barrett P, Barry Z, ... ... During M, et al. US immigration order strikes against biotech. Nature Biotechnology. 35: 204-206. PMID 28267733 DOI: 10.1038/Nbt.3824  0.164
1998 Song S, Wang Y, Bak S, During MJ, Bryan J, Ashe O, Ullrey DB, Trask LE, Grant FD, O’Malley KL, Riedel H, Goldstein DS, Neve KA, LaHoste GJ, Marshall JF, et al. Modulation of Rat Rotational Behavior by Direct Gene Transfer of Constitutively Active Protein Kinase C into Nigrostriatal Neurons The Journal of Neuroscience. 18: 4119-4132. DOI: 10.1523/JNEUROSCI.18-11-04119.1998  0.164
1999 Walton M, Woodgate AM, Muravlev A, Xu R, During MJ, Dragunow M. CREB phosphorylation promotes nerve cell survival. Journal of Neurochemistry. 73: 1836-42. PMID 10537041  0.164
2017 Iyirhiaro GO, Soon Im D, Boonying W, Callaghan SM, During MJ, Slack RS, Park DS. Cdc25A is a critical mediator of ischemic neuronal death in vitro and in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28607169 DOI: 10.1523/Jneurosci.3017-16.2017  0.164
1993 Young RS, During MJ, Donnelly DF, Aquila WJ, Perry VL, Haddad GG. Effect of anoxia on excitatory amino acids in brain slices of rats and turtles: in vitro microdialysis. The American Journal of Physiology. 264: R716-9. PMID 8097385  0.164
1999 Young D, Lawlor PA, Leone P, Dragunow M, During MJ. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nature Medicine. 5: 448-53. PMID 10202938 DOI: 10.1038/7449  0.163
2007 Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 369: 2097-105. PMID 17586305 DOI: 10.1016/S0140-6736(07)60982-9  0.163
2012 Leone P, Shera D, McPhee SW, Francis JS, Kolodny EH, Bilaniuk LT, Wang DJ, Assadi M, Goldfarb O, Goldman HW, Freese A, Young D, During MJ, Samulski RJ, Janson CG. Long-term follow-up after gene therapy for canavan disease. Science Translational Medicine. 4: 165ra163. PMID 23253610 DOI: 10.1126/Scitranslmed.3003454  0.161
2003 Haile CN, During MJ, Jatlow PI, Kosten TR, Kosten TA. Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biological Psychiatry. 54: 915-21. PMID 14573319 DOI: 10.1016/S0006-3223(03)00241-5  0.159
2022 Salamone A, Terrone G, Di Sapia R, Balosso S, Ravizza T, Beltrame L, Craparotta I, Mannarino L, Cominesi SR, Rizzi M, Pauletti A, Marchini S, Porcu L, Zimmer TS, Aronica E, ... During M, et al. Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy. Neurobiology of Disease. 105835. PMID 35932989 DOI: 10.1016/j.nbd.2022.105835  0.156
1995 During MJ, Leone P. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders. Clinical Neuroscience (New York, N.Y.). 3: 292-300. PMID 8914796  0.156
2003 Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. The European Journal of Neuroscience. 18: 2087-92. PMID 14622242 DOI: 10.1046/j.1460-9568.2003.02926.x  0.156
2006 Lin EJ, Sainsbury A, Lee NJ, Boey D, Couzens M, Enriquez R, Slack K, Bland R, During MJ, Herzog H. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology. 147: 5094-101. PMID 16873543 DOI: 10.1210/en.2006-0097  0.156
2009 Sørensen AT, Nikitidou L, Ledri M, Lin EJ, During MJ, Kanter-Schlifke I, Kokaia M. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Experimental Neurology. 215: 328-33. PMID 19038255 DOI: 10.1016/j.expneurol.2008.10.015  0.154
2014 Carruthers KH, Metzger G, During MJ, Muravlev A, Wang C, Kocak E. Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models. Cancer Gene Therapy. 21: 434-40. PMID 25236494 DOI: 10.1038/cgt.2014.47  0.154
2000 Telfeian AE, Federoff HJ, Leone P, During MJ, Williamson A. Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro. Neurobiology of Disease. 7: 362-74. PMID 10964607 DOI: 10.1006/Nbdi.2000.0294  0.154
1990 Sabel BA, Dominiak P, Hüaser W, During MJ, Freese A. Extended levodopa release from a subcutaneously implanted polymer matrix in rats. Annals of Neurology. 28: 714-7. PMID 2260860 DOI: 10.1002/ana.410280519  0.154
2009 Kalev-Zylinska ML, Symes W, Young D, During MJ. Knockdown and overexpression of NR1 modulates NMDA receptor function. Molecular and Cellular Neurosciences. 41: 383-96. PMID 19394426 DOI: 10.1016/j.mcn.2009.04.003  0.152
1992 Young RS, During MJ, Aquila WJ, Tendler D, Ley E. Hypoxia increases extracellular concentrations of excitatory and inhibitory neurotransmitters in subsequently induced seizure: in vivo microdialysis study in the rabbit. Experimental Neurology. 117: 204-9. PMID 1354167  0.151
2004 Trapasso F, Yendamuri S, Dumon KR, Iuliano R, Cesari R, Feig B, Seto R, Infante L, Ishii H, Vecchione A, During MJ, Croce CM, Fusco A. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis. 25: 2107-14. PMID 15231692 DOI: 10.1093/Carcin/Bgh224  0.151
1990 Sabel BA, Freese A, During MJ. Controlled-release dopamine polymers as a novel approach to the treatment of Parkinson's disease. Advances in Neurology. 53: 513-8. PMID 2239492  0.15
2011 LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, ... ... During MJ, et al. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. The Lancet. Neurology. 10: 309-19. PMID 21419704 DOI: 10.1016/S1474-4422(11)70039-4  0.15
2002 Fitzsimons HL, Bland RJ, During MJ. Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods (San Diego, Calif.). 28: 227-36. PMID 12413421 DOI: 10.1016/S1046-2023(02)00227-X  0.149
2008 Noè F, Pool AH, Nissinen J, Gobbi M, Bland R, Rizzi M, Balducci C, Ferraguti F, Sperk G, During MJ, Pitkänen A, Vezzani A. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain : a Journal of Neurology. 131: 1506-15. PMID 18477594 DOI: 10.1093/brain/awn079  0.149
2001 Janson CG, McPhee SW, Leone P, Freese A, During MJ. Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends in Neurosciences. 24: 706-12. PMID 11718875 DOI: 10.1016/S0166-2236(00)01954-8  0.149
1998 During MJ, Xu R, Young D, Kaplitt MG, Sherwin RS, Leone P. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nature Medicine. 4: 1131-5. PMID 9771745 DOI: 10.1038/2625  0.148
2018 Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ, Kaplitt MG, Eidelberg D. Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity. Science Translational Medicine. 10. PMID 30487248 DOI: 10.1126/Scitranslmed.Aau0713  0.148
2003 Pearson AG, Gray CW, Pearson JF, Greenwood JM, During MJ, Dragunow M. ATF3 enhances c-Jun-mediated neurite sprouting. Brain Research. Molecular Brain Research. 120: 38-45. PMID 14667575 DOI: 10.1016/J.Molbrainres.2003.09.014  0.146
2005 Rashidian J, Iyirhiaro G, Aleyasin H, Rios M, Vincent I, Callaghan S, Bland RJ, Slack RS, During MJ, Park DS. Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 14080-5. PMID 16166266 DOI: 10.1073/Pnas.0500099102  0.146
2001 Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, Mancini R, Vecchione A, Baffa R, Trapasso F, During MJ, Huebner K, Croce CM. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 3346-51. PMID 11248081 DOI: 10.1073/Pnas.061020098  0.146
2014 Tsang VW, Young D, During MJ, Birch NP. AAV-mediated overexpression of neuroserpin in the hippocampus decreases PSD-95 expression but does not affect hippocampal-dependent learning and memory. Plos One. 9: e91050. PMID 24608243 DOI: 10.1371/journal.pone.0091050  0.145
2009 Rashidian J, Rousseaux MW, Venderova K, Qu D, Callaghan SM, Phillips M, Bland RJ, During MJ, Mao Z, Slack RS, Park DS. Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 12497-505. PMID 19812325 DOI: 10.1523/Jneurosci.3892-09.2009  0.143
2014 Iyirhiaro GO, Zhang Y, Estey C, O'Hare MJ, Safarpour F, Parsanejad M, Wang S, Abdel-Messih E, Callaghan SM, During MJ, Slack RS, Park DS. Regulation of ischemic neuronal death by E2F4-p130 protein complexes. The Journal of Biological Chemistry. 289: 18202-13. PMID 24828495 DOI: 10.1074/Jbc.M114.574145  0.143
2017 Patrício MI, Barnard AR, Green AL, During MJ, Sen A, MacLaren RE. A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line. Seizure. 55: 25-29. PMID 29367144 DOI: 10.1016/j.seizure.2017.12.005  0.142
1995 Boulanger LM, Lombroso PJ, Raghunathan A, During MJ, Wahle P, Naegele JR. Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1532-44. PMID 7869116 DOI: 10.1523/Jneurosci.15-02-01532.1995  0.142
2001 Dumon KR, Ishii H, Vecchione A, Trapasso F, Baldassarre G, Chakrani F, Druck T, Rosato EF, Williams NN, Baffa R, During MJ, Huebner K, Croce CM. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Research. 61: 4827-36. PMID 11406559  0.142
2004 Harrop JS, Poulsen DJ, Xiao W, Freese A, During MJ. Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytes. Spine. 29: 2787-92. PMID 15599280 DOI: 10.1097/01.Brs.0000147909.59083.Da  0.14
2000 During MJ, Symes CW, Lawlor PA, Lin J, Dunning J, Fitzsimons HL, Poulsen D, Leone P, Xu R, Dicker BL, Lipski J, Young D. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (New York, N.Y.). 287: 1453-60. PMID 10688787 DOI: 10.1126/Science.287.5457.1453  0.138
2008 Jung AE, Fitzsimons HL, Bland RJ, During MJ, Young D. HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1048-55. PMID 18398426 DOI: 10.1038/mt.2008.68  0.136
1994 Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. The Journal of Clinical Investigation. 93: 1677-82. PMID 8163668 DOI: 10.1172/Jci117150  0.136
2011 Lin EJ, Choi E, Liu X, Martin A, During MJ. Environmental enrichment exerts sex-specific effects on emotionality in C57BL/6J mice. Behavioural Brain Research. 216: 349-57. PMID 20732356 DOI: 10.1016/j.bbr.2010.08.019  0.136
1990 Freese A, Swartz KJ, During MJ, Martin JB. Kynurenine metabolites of tryptophan: implications for neurologic diseases. Neurology. 40: 691-5. PMID 2181342 DOI: 10.1212/WNL.40.4.691  0.134
1995 During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. The Journal of Clinical Investigation. 95: 2403-8. PMID 7738204 DOI: 10.1172/JCI117935  0.131
2001 Jung SC, Han IP, Limaye A, Xu R, Gelderman MP, Zerfas P, Tirumalai K, Murray GJ, During MJ, Brady RO, Qasba P. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 2676-81. PMID 11226298 DOI: 10.1073/Pnas.051634498  0.129
2007 Baldock PA, Allison SJ, Lundberg P, Lee NJ, Slack K, Lin EJ, Enriquez RF, McDonald MM, Zhang L, During MJ, Little DG, Eisman JA, Gardiner EM, Yulyaningsih E, Lin S, et al. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. The Journal of Biological Chemistry. 282: 19092-102. PMID 17491016 DOI: 10.1074/jbc.M700644200  0.128
2019 Cogram P, Deacon RMJ, Warner-Schmidt JL, von Schimmelmann MJ, Abrahams BS, During MJ. Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome. Frontiers in Behavioral Neuroscience. 13: 141. PMID 31293404 DOI: 10.3389/Fnbeh.2019.00141  0.128
1990 Swartz K, During M, Freese A, Beal M. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors The Journal of Neuroscience. 10: 2965-2973. DOI: 10.1523/JNEUROSCI.10-09-02965.1990  0.127
2004 Banks WA, During MJ, Niehoff ML. Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. The Journal of Pharmacology and Experimental Therapeutics. 309: 469-75. PMID 14724226 DOI: 10.1124/jpet.103.063222  0.127
2019 Weston M, Kaserer T, Wu A, Mouravlev A, Carpenter JC, Snowball A, Knauss S, von Schimmelmann M, During MJ, Lignani G, Schorge S, Young D, Kullmann DM, Lieb A. Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics. Science Advances. 5: eaaw1567. PMID 31001591 DOI: 10.1126/Sciadv.Aaw1567  0.127
2007 Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, During MJ, Eidelberg D. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 104: 19559-64. PMID 18042721 DOI: 10.1073/Pnas.0706006104  0.126
2011 Cao L, Choi EY, Liu X, Martin A, Wang C, Xu X, During MJ, Fierabracci P, Martinelli S, Scabia G. “Trasformazione” fenotipica da tessuto adiposo bianco a tessuto adiposo bruno mediante attivazione genetica ed ambientale dell’asse ipotalamo-adipocita L'Endocrinologo. 12: 312-313. DOI: 10.1007/BF03344864  0.126
1996 Tan WK, Williams CE, During MJ, Mallard CE, Gunning MI, Gunn AJ, Gluckman PD. Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatric Research. 39: 791-7. PMID 8726230 DOI: 10.1203/00006450-199605000-00008  0.125
2015 Kamal T, Green TN, Morel-Kopp MC, Ward CM, McGregor AL, McGlashan SR, Bohlander SK, Browett PJ, Teague L, During MJ, Skerry TM, Josefsson EC, Kalev-Zylinska ML. Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation. Cellular Signalling. PMID 25982509 DOI: 10.1016/j.cellsig.2015.05.004  0.125
1997 During MJ, Leone P. Targets for gene therapy of Parkinson's disease: growth factors, signal transduction, and promoters. Experimental Neurology. 144: 74-81. PMID 9126155 DOI: 10.1006/exnr.1996.6391  0.122
1992 During MJ, Craig JS, Hernandez TD, Anderson GM, Gallager DW. Effect of amygdala kindling on the in vivo release of GABA and 5-HT in the dorsal raphe nucleus in freely moving rats. Brain Research. 584: 36-44. PMID 1515952 DOI: 10.1016/0006-8993(92)90875-A  0.121
1990 Sabel BA, Dominiak P, Häuser W, During MJ, Freese A. Levodopa delivery from controlled-release polymer matrix: delivery of more than 600 days in vitro and 225 days of elevated plasma levels after subcutaneous implantation in rats. The Journal of Pharmacology and Experimental Therapeutics. 255: 914-22. PMID 2243358  0.12
2021 Hawkins NA, Jurado M, Thaxton TT, Duarte SE, Barse L, Tatsukawa T, Yamakawa K, Nishi T, Kondo S, Miyamoto M, Abrahams BS, During MJ, Kearney JA. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice. Epilepsia. PMID 34510432 DOI: 10.1111/epi.17062  0.12
2007 Aleyasin H, Rousseaux MW, Phillips M, Kim RH, Bland RJ, Callaghan S, Slack RS, During MJ, Mak TW, Park DS. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proceedings of the National Academy of Sciences of the United States of America. 104: 18748-53. PMID 18003894 DOI: 10.1073/Pnas.0709379104  0.12
2016 Carruthers KH, Metzger G, Choi E, During MJ, Kocak E. A Therapeutic Role for Survivin in Mitigating the Harmful Effects of Ionizing Radiation. Sarcoma. 2016: 1830849. PMID 27190495 DOI: 10.1155/2016/1830849  0.119
2003 Ishii H, Zanesi N, Vecchione A, Trapasso F, Yendamuri S, Sarti M, Baffa R, During MJ, Huebner K, Fong LY, Croce CM. Regression of upper gastric cancer in mice by FHIT gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1768-70. PMID 12958204 DOI: 10.1096/Fj.03-0241Fje  0.119
1997 During MJ. Adeno-associated virus as a gene delivery system. Advanced Drug Delivery Reviews. 27: 83-94. PMID 10837553  0.118
2012 Cittadini A, Monti MG, Iaccarino G, Castiello MC, Baldi A, Bossone E, Longobardi S, Marra AM, Petrillo V, Saldamarco L, During MJ, Saccà L, Condorelli G. SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cardiovascular Research. 96: 381-90. PMID 22875468 DOI: 10.1093/Cvr/Cvs261  0.117
2006 Mouravlev A, Dunning J, Young D, During MJ. Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats. Proceedings of the National Academy of Sciences of the United States of America. 103: 4705-10. PMID 16537429 DOI: 10.1073/pnas.0506137103  0.117
2015 Lin EJ, Sun M, Choi EY, Magee D, Stets CW, During MJ. Social overcrowding as a chronic stress model that increases adiposity in mice. Psychoneuroendocrinology. 51: 318-30. PMID 25462904 DOI: 10.1016/j.psyneuen.2014.10.007  0.114
2007 Kalev-Zylinska ML, During MJ. Paradoxical facilitatory effect of low-dose alcohol consumption on memory mediated by NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10456-67. PMID 17898217 DOI: 10.1523/JNEUROSCI.2789-07.2007  0.114
1999 Leone P, Janson CG, McPhee SJ, During MJ. Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease. Current Opinion in Molecular Therapeutics. 1: 487-92. PMID 11713764  0.111
2017 Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, ... ... During MJ, et al. Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. Jci Insight. 2: e90133. PMID 28405611 DOI: 10.1172/Jci.Insight.90133  0.107
2014 Sun M, Choi EY, Magee DJ, Stets CW, During MJ, Lin EJ. Metabolic Effects of Social Isolation in Adult C57BL/6 Mice. International Scholarly Research Notices. 2014: 690950. PMID 27433503 DOI: 10.1155/2014/690950  0.107
2017 De Silva SR, Barnard AR, Hughes S, Tam SKE, Martin C, Singh MS, Barnea-Cramer AO, McClements ME, During MJ, Peirson SN, Hankins MW, MacLaren RE. Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 28973921 DOI: 10.1073/pnas.1701589114  0.106
2003 Reid SJ, Rees MI, van Roon-Mom WM, Jones AL, MacDonald ME, Sutherland G, During MJ, Faull RL, Owen MJ, Dragunow M, Snell RG. Molecular investigation of TBP allele length: a SCA17 cellular model and population study. Neurobiology of Disease. 13: 37-45. PMID 12758065 DOI: 10.1016/S0969-9961(03)00014-7  0.105
2006 Kaplitt MG, During MJ. Gene Therapy of the Central Nervous System: From Bench to Bedside Gene Therapy of the Central Nervous System: From Bench to Bedside 0.105
1998 During MJ, Ashenden LM. Towards gene therapy for the central nervous system. Molecular Medicine Today. 4: 485-93. PMID 9857368  0.105
2003 During MJ. Gene therapy in Parkinson's disease. Expert Review of Neurotherapeutics. 3: 729-32. PMID 19810875 DOI: 10.1586/14737175.3.6.729  0.104
2017 Green TN, Hamilton JR, Morel-Kopp MC, Zheng Z, Chen TT, Hearn JI, Sun PP, Flanagan JU, Young D, Barber PA, During MJ, Ward CM, Kalev-Zylinska ML. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis. Platelets. 1-13. PMID 28277064 DOI: 10.1080/09537104.2017.1280149  0.103
2007 Kalev-Zylinska ML, Blacklock HA, Royle G, Henderson R, Flanagan P, Jackson S, Dilshan I, Symes W, Goldstone K, Browett P, During MJ. Antibodies Targeting Subunit 1 of the N-Methyl-D-Aspartate Receptor May Contribute to Immune Mediated Thrombocytopenia. Blood. 110: 2110-2110. DOI: 10.1182/blood.v110.11.2110.2110  0.101
2003 Baer K, Waldvogel HJ, During MJ, Snell RG, Faull RL, Rees MI. Association of gephyrin and glycine receptors in the human brainstem and spinal cord: an immunohistochemical analysis. Neuroscience. 122: 773-84. PMID 14622920 DOI: 10.1016/S0306-4522(03)00543-8  0.101
2018 Kamal T, Green TN, Hearn JI, Josefsson EC, Morel-Kopp MC, Ward CM, During MJ, Kalev-Zylinska ML. -methyl-d-aspartate receptor mediated calcium influx supports in vitro differentiation of normal mouse megakaryocytes but proliferation of leukemic cell lines. Research and Practice in Thrombosis and Haemostasis. 2: 125-138. PMID 30046713 DOI: 10.1002/rth2.12068  0.1
2009 Jendle J, Nauck MA, Matthews DR, Frid A, Hermansen K, Düring M, Zdravkovic M, Strauss BJ, Garber AJ. Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes, Obesity & Metabolism. 11: 1163-72. PMID 19930006 DOI: 10.1111/j.1463-1326.2009.01158.x  0.097
2005 Xu R, Rahimi M, Ma H, Fung P, Chang C, Xu S, During M. Stability of infectious recombinant adeno-associated viral vector in gene delivery. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 11: BR305-8. PMID 16127351  0.097
1995 Maggs DG, Jacob R, Rife F, Lange R, Leone P, During MJ, Tamborlane WV, Sherwin RS. Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle. The Journal of Clinical Investigation. 96: 370-7. PMID 7615807 DOI: 10.1172/JCI118043  0.096
2014 Ko JH, Feigin A, Mattis PJ, Tang CC, Ma Y, Dhawan V, During MJ, Kaplitt MG, Eidelberg D. Network modulation following sham surgery in Parkinson's disease. The Journal of Clinical Investigation. 124: 3656-66. PMID 25036712 DOI: 10.1172/Jci75073  0.095
2014 Kalev-Zylinska ML, Green TN, Morel-Kopp MC, Sun PP, Park YE, Lasham A, During MJ, Ward CM. N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets. Thrombosis Research. 133: 837-47. PMID 24593912 DOI: 10.1016/j.thromres.2014.02.011  0.095
2021 Feja M, Meller S, Deking LS, Kaczmarek E, During MJ, Silverman RB, Gernert M. OV329, a novel highly potent γ-aminobutyric acid aminotransferase inactivator, induces pronounced anticonvulsant effects in the pentylenetetrazole seizure threshold test and in amygdala-kindled rats. Epilepsia. 62: 3091-3104. PMID 34617595 DOI: 10.1111/epi.17090  0.094
2014 MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Clark KR, During MJ, Cremers FP, Black GC, Lotery AJ, Downes SM, Webster AR, Seabra MC. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet (London, England). 383: 1129-37. PMID 24439297 DOI: 10.1016/S0140-6736(13)62117-0  0.092
2006 Noé F, During MJ, Vezzani A. Gene Therapy for Epilepsy Gene Therapy of the Central Nervous System: From Bench to Bedside. 151-163. DOI: 10.1016/B978-012397632-1/50013-7  0.092
2016 D'mello SA, Joseph WR, Green TN, Leung EY, During MJ, Finlay GJ, Baguley BC, Kalev-Zylinska ML. Selected GRIN2A mutations in melanoma cause oncogenic effects that can be modulated by extracellular glutamate. Cell Calcium. PMID 27659111 DOI: 10.1016/j.ceca.2016.09.003  0.091
2007 Lawlor PA, Bland RJ, Das P, Price RW, Holloway V, Smithson L, Dicker BL, During MJ, Young D, Golde TE. Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Abeta levels. Molecular Neurodegeneration. 2: 11. PMID 17559680 DOI: 10.1186/1750-1326-2-11  0.09
2006 Kaplitt MG, Eidelberg D, Feigin A, Fitzimmons H, Lawlor P, Strybing K, Cox M, Tang C, Bland R, During MJ. 727. Improvements in Clinical and Radiographic Outcomes in a Phase I Study of AAV-GAD Gene Therapy for Parkinson's Disease Molecular Therapy. 13: S280-S281. DOI: 10.1016/J.Ymthe.2006.08.807  0.089
1996 During M. Gene therapy chronology. Science (New York, N.Y.). 273: 416-7. PMID 8677433  0.087
1993 Thomas-Reetz A, Hell JW, During MJ, Walch-Solimena C, Jahn R, De Camilli P. A gamma-aminobutyric acid transporter driven by a proton pump is present in synaptic-like microvesicles of pancreatic beta cells. Proceedings of the National Academy of Sciences of the United States of America. 90: 5317-21. PMID 8506380 DOI: 10.1073/Pnas.90.11.5317  0.083
2013 Kalev-Zylinska ML, Symes W, Little KC, Sun P, Wen D, Qiao L, Young D, During MJ, Barber PA. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Stroke; a Journal of Cerebral Circulation. 44: 2212-9. PMID 23723305 DOI: 10.1161/STROKEAHA.113.001235  0.082
1993 Kerr D, Sherwin RS, Pavalkis F, Fayad PB, Sikorski L, Rife F, Tamborlane WV, During MJ. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Annals of Internal Medicine. 119: 799-804. PMID 8379601 DOI: 10.7326/0003-4819-119-8-199310150-00005  0.082
1995 Kaiser MG, During MJ. Combining laser Doppler flowmetry with microdialysis: a novel approach to investigate the coupling of regional cerebral blood flow to neuronal activity. Journal of Neuroscience Methods. 60: 165-73. PMID 8544476  0.08
1994 Scheyer RD, During MJ, Cramer JA, Toftness BR, Hochholzer JM, Mattson RH. Simultaneous HPLC Analysis of Carbamazepine and Carbamazepine Epoxide in Human Brain Microdialysate Journal of Liquid Chromatography. 17: 1567-1576. DOI: 10.1080/10826079408013179  0.077
1998 Mattson RH, Scheyer RD, Petroff OA, During MJ, Collins TL, Spencer D. Novel methods for studying new antiepileptic drug pharmacology. Advances in Neurology. 76: 105-12. PMID 9408467  0.077
2012 Yao M, Jouvent E, During M, Godin O, Hervé D, Guichard JP, Zhu YC, Gschwendtner A, Opherk C, Dichgans M, Chabriat H. Extensive white matter hyperintensities may increase brain volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke; a Journal of Cerebral Circulation. 43: 3252-7. PMID 23185048 DOI: 10.1161/STROKEAHA.112.664854  0.074
2002 Poulsen DJ, Harrop JS, During MJ. Gene therapy for spinal cord injury and disease. The Journal of Spinal Cord Medicine. 25: 2-9. PMID 11939461  0.063
1996 During MJ. Gene trial in New Zealand. Lancet. 348: 618. PMID 8774596 DOI: 10.1016/S0140-6736(05)64836-2  0.063
2014 D'mello SA, Flanagan JU, Green TN, Leung EY, Askarian-Amiri ME, Joseph WR, McCrystal MR, Isaacs RJ, Shaw JH, Furneaux CE, During MJ, Finlay GJ, Baguley BC, Kalev-Zylinska ML. Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival. Frontiers in Oncology. 3: 333. PMID 24455489 DOI: 10.3389/fonc.2013.00333  0.06
1985 Havelaar AH, During M, Delfgou-Van Asch EH. Comparative study of membrane filtration and enrichment media for the isolation and enumeration of Pseudomonas aeruginosa from sewage, surface water, and swimming pools. Canadian Journal of Microbiology. 31: 686-92. PMID 3935304  0.059
2003 Dunning J, During MJ. Molecular mechanisms of learning and memory. Expert Reviews in Molecular Medicine. 5: 1-11. PMID 14987400 DOI: doi:10.1017/S1462399403006707  0.059
1993 Ochi S, Lim JY, Rand MN, During MJ, Sakatani K, Kocsis JD. Transient presence of GABA in astrocytes of the developing optic nerve. Glia. 9: 188-98. PMID 8294149 DOI: 10.1002/glia.440090304  0.054
1999 During M. Clinical Companion to The Molecular and Genetic Basis of Neurological Disease, Second Edition Neurosurgery. 45: 953-954. DOI: 10.1097/00006123-199910000-00058  0.053
1999 During MJ, Janson CG. PNAs breach the blood-brain barrier? Nature Biotechnology. 17: 753-4. PMID 10429237 DOI: 10.1038/11684  0.053
2012 Benisty S, Reyes S, Godin O, Hervé D, Zieren N, Jouvent E, Zhu Y, During M, Dichgans M, Chabriat H. White-matter lesions without lacunar infarcts in CADASIL. Journal of Alzheimer's Disease : Jad. 29: 903-11. PMID 22330818 DOI: 10.3233/JAD-2012-111784  0.053
2021 Halford JJ, Sperling MR, Arkilo D, Asgharnejad M, Zinger C, Xu R, During M, French JA. A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies. Epilepsy Research. 174: 106646. PMID 33940389 DOI: 10.1016/j.eplepsyres.2021.106646  0.048
1987 Havelaar AH, During M, Versteegh JF. Ampicillin-dextrin agar medium for the enumeration of Aeromonas species in water by membrane filtration. The Journal of Applied Bacteriology. 62: 279-87. PMID 3597206  0.048
2006 Fitzsimons HL, During MJ. Design and Optimization of Expression Cassettes Including Promoter Choice and Regulatory Elements Gene Therapy of the Central Nervous System: From Bench to Bedside. 3-16. DOI: 10.1016/B978-012397632-1/50002-2  0.047
2020 Park YE, Penumarthy R, Sun PP, Kang CY, Morel-Kopp MC, Downing J, Green TN, Immanuel T, Ward CM, Young D, During MJ, Barber PA, Kalev-Zylinska ML. Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective Mechanism. International Journal of Molecular Sciences. 21. PMID 33182365 DOI: 10.3390/ijms21218398  0.047
2004 Young D, During MJ. Using the immune system to target epilepsy. Advances in Experimental Medicine and Biology. 548: 134-44. PMID 15250592  0.045
2010 Jacqmin M, Hervé D, Viswanathan A, Guichard JP, During M, Dichgans M, Chabriat H. Confluent thalamic hyperintensities in CADASIL. Cerebrovascular Diseases (Basel, Switzerland). 30: 308-13. PMID 20664266 DOI: 10.1159/000319607  0.044
1985 Havelaar AH, During M. Model studies on a membrane filtration method for the enumeration of coagulase-positive staphylococci in swimming-pool water using rabbit plasma-bovine fibrinogen agar. Canadian Journal of Microbiology. 31: 331-4. PMID 4005714  0.041
2005 Schets FM, Engels GB, During M, de Roda Husman AM. Detection of infectious Cryptosporidium oocysts by cell culture immunofluorescence assay: applicability to environmental samples. Applied and Environmental Microbiology. 71: 6793-8. PMID 16269711 DOI: 10.1128/AEM.71.11.6793-6798.2005  0.036
1988 Havelaar AH, During M. Evaluation of the Anderson Baird-Parker direct plating method for enumerating Escherichia coli in water. The Journal of Applied Bacteriology. 64: 89-98. PMID 3280542  0.031
1988 During MJ, Freese A. Is L-tryptophan safe? The Australian and New Zealand Journal of Psychiatry. 22: 339. PMID 3240200  0.03
2001 Janson CG, Ramesh TM, During MJ, Leone P, Heywood J. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. Journal of Hematotherapy & Stem Cell Research. 10: 913-5. PMID 11798518 DOI: 10.1089/152581601317211015  0.029
1990 Havelaar AH, Guinée PA, During M, Peeters MF. [Aeromonas species as cause of diarrhea and infections outside the gastrointestinal tract in The Netherlands]. Nederlands Tijdschrift Voor Geneeskunde. 134: 1053-7. PMID 2366898  0.027
1986 Havelaar AH, During M. C-390 as sole selective agent for isolation of Pseudomonas aeruginosa from hospital waste water. Canadian Journal of Microbiology. 32: 513-5. PMID 3089569  0.027
1990 Havelaar AH, Versteegh JF, During M. The presence of Aeromonas in drinking water supplies in The Netherlands. Zentralblatt Fã¼R Hygiene Und Umweltmedizin = International Journal of Hygiene and Environmental Medicine. 190: 236-56. PMID 2261055  0.026
2018 Kolevzon A, Bird LM, Burdine RD, During M, Grieco J, Visootsak J, Thibert RL. 3.1 Topline Results From a Phase 2 Adult and Adolescent Angelman Syndrome Clinical Trial: A Randomized, Double-Blind, Safety and Efficacy Study of Gaboxadol (Ov101) Journal of the American Academy of Child & Adolescent Psychiatry. 57: S182. DOI: 10.1016/J.Jaac.2018.09.159  0.024
1995 Geller AI, Naegele JR, O'Malley KL, During MJ. Response Science. 269: 856-857. DOI: 10.1126/science.269.5225.856-a  0.023
2013 Nauck M, Frid A, Hermansen K, Thomsen AB, During M, Shah N, Tankova T, Mitha I, Matthews DR. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study. Diabetes, Obesity & Metabolism. 15: 204-12. PMID 22985213 DOI: 10.1111/dom.12012  0.022
2005 Schets FM, During M, Italiaander R, Heijnen L, Rutjes SA, van der Zwaluw WK, de Roda Husman AM. Escherichia coli O157:H7 in drinking water from private water supplies in the Netherlands. Water Research. 39: 4485-93. PMID 16219332 DOI: 10.1016/j.watres.2005.08.025  0.02
1989 Seymour FW, Brock P, During M, Poole G. Reducing sleep disruptions in young children: evaluation of therapist-guided and written information approaches: a brief report. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 30: 913-8. PMID 2687306  0.018
2005 Viehweger B, Karabet A, During M, Schaeffer L. Forging of Mg-alloys AZ31 and AZ80 Materialwissenschaft Und Werkstofftechnik. 36: 211-217. DOI: 10.1002/mawe.200400856  0.018
2020 Bird LM, Ochoa-Lubinoff C, Tan WH, Heimer G, Melmed RD, Rakhit A, Visootsak J, During MJ, Holcroft C, Burdine RD, Kolevzon A, Thibert RL. The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome. Neurology. PMID 33443117 DOI: 10.1212/WNL.0000000000011409  0.017
1994 Hoogenboom-Verdegaal AM, de Jong JC, During M, Hoogenveen R, Hoekstra JA. Community-based study of the incidence of gastrointestinal diseases in The Netherlands. Epidemiology and Infection. 112: 481-7. PMID 8005214  0.016
2006 Kaplitt MG, During MJ. Preface Gene Therapy of the Central Nervous System: From Bench to Bedside. xiii-xiv. DOI: 10.1016/B978-012397632-1/50001-0  0.011
2014 Novak J, Micheel I, Melenhorst M, Wieneke L, During M, Moron JG, Pasini C, Tagliasacchi M, Fraternali P. HistoGraph - A visualization tool for collaborative analysis of networks from historical social multimedia collections Proceedings of the International Conference On Information Visualisation. 241-250. DOI: 10.1109/IV.2014.47  0.01
Hide low-probability matches.